<DOC>
	<DOCNO>NCT01532232</DOCNO>
	<brief_summary>Breast cancer patient smoke , great risk treatment complication . The purpose study see researcher find way help patient breast cancer quit smoke . They compare two way help people quit smoking . Some patient receive varenicline , prescription medicine also know Chantix , Â® . Other patient receive placebo drug . A placebo inactive substance contains medicine . All patient receive smoke cessation counseling provide tobacco treatment specialist . They hope researcher learn study help u improve smoke cessation treatment program breast cancer patient .</brief_summary>
	<brief_title>Tobacco Dependence Breast Cancer Patients Trial Varenicline ( Chantix )</brief_title>
	<detailed_description />
	<mesh_term>Breast Neoplasms</mesh_term>
	<mesh_term>Tobacco Use Disorder</mesh_term>
	<mesh_term>Varenicline</mesh_term>
	<criteria>MSK patient diagnose breast cancer mass suspicious breast cancer time enrollment , per clinician judgment EMR ; Selfreported current cigarette smoker ( defined daily smoke past seven day ) Advised quit smoking MSK physician willing receive smoking cessation counsel treatment ; per self report Fluent English Patients le 18 year age safety efficacy varenicline yet test child ; Evidence know suspect medical contraindication use varenicline ( e.g. , recent ( within past two month ) cardiovascular instability ( include myocardial infarction unstable angina ; uncontrolled hypertension , significant neurological sequela cerebrovascular disease , severe congestive heart failure ( New York Heart Association class III IV ) , severe chronic obstructive pulmonary disease ; uncontrolled gastrointestinal , hepatic , endocrine disease ; severe renal impairment . Selfreported evidence significant psychiatric history ( e.g. , schizophrenia , unstable bipolar disorder , panic disorder , untreated major depression ) sufficient , investigator ' judgment , preclude participation clinical trial ; Selfreported evidence recent substance abuse heavy alcohol use ( &gt; 14 drink weekly ) last 6 month ; Selfreported recent use ( past 30 day ) plan use nicotine replacement therapy ( NRT ) FDA approve cessation pharmacotherapy ( bupropion ) ; Premenopausal woman pregnant per EMR Women breastfeed per selfreport .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2015</verification_date>
	<keyword>PLACEBO</keyword>
	<keyword>VARENICLINE ( CHANTIX )</keyword>
	<keyword>Self-reported cigarette smoker</keyword>
	<keyword>Smoking Cessation</keyword>
	<keyword>11-136</keyword>
</DOC>